Free Trial
→ Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (From Colonial Metals) (Ad) Free IONS Stock Alerts

Ionis Pharmaceuticals (IONS) SEC Filings & 10K Form

Ionis Pharmaceuticals logo
$32.33 -0.36 (-1.11%)
Closing price 02/21/2025 03:59 PM Eastern
Extended Trading
$32.40 +0.07 (+0.23%)
As of 02/21/2025 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Ionis Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/19/2025
3:06 PM		Ionis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
3:53 PM		Capital World Investors (Filed by)
Ionis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/07/2025
10:55 AM		Ionis Pharmaceuticals (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
Form SCHEDULE 13G/A
02/06/2025
5:26 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
5:27 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:56 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:26 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:26 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
6:27 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
4:43 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:41 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:01 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:02 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
4:03 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:58 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:59 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:40 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:40 PM		Ionis Pharmaceuticals (Issuer)
Jenne Kyle (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2025
6:41 PM		Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2025
6:31 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:18 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:19 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:21 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:22 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:23 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:25 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:28 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Watch This Robotics Demo Before March 17th (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

Click here to watch the demo…
01/16/2025
6:29 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2025
6:30 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2025
10:29 AM		Ionis Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/06/2025
3:52 PM		Baroldi Joseph (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
3:52 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:57 PM		Hayden Michael R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
1:28 PM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:34 PM		BB BIOTECH AG (Filed by)
Ionis Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
7:55 AM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
11/08/2024
9:52 AM		Ionis Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/06/2024
3:06 PM		Ionis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
5:39 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
5:42 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
5:01 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
5:01 PM		Devers Shannon L. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
4:19 PM		Ionis Pharmaceuticals (Filer)
Form 424B5
09/09/2024
3:33 PM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2024
3:23 PM		Ionis Pharmaceuticals (Filer)
Form 424B5
09/04/2024
8:43 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:43 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:23 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:24 PM		Ionis Pharmaceuticals (Subject)
O'NEIL PATRICK R. (Reporting)
Form 144/A
09/04/2024
8:25 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:27 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:29 PM		Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:33 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
8:33 PM		Ionis Pharmaceuticals (Subject)
Monia Brett P (Reporting)
Form 144/A
09/04/2024
8:40 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:40 PM		Birchler Brian (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:41 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:19 PM		Ionis Pharmaceuticals (Subject)
Swayze Eric (Reporting)
Form 144/A
09/04/2024
8:20 PM		Ionis Pharmaceuticals (Subject)
Schneider Eugene (Reporting)
Form 144/A
09/04/2024
8:21 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144/A
09/04/2024
8:02 PM		Ionis Pharmaceuticals (Issuer)
Swayze Eric (Reporting)
Form 4/A
09/04/2024
8:06 PM		Ionis Pharmaceuticals (Issuer)
Schneider Eugene (Reporting)
Form 4/A
09/04/2024
8:11 PM		Ionis Pharmaceuticals (Issuer)
O'NEIL PATRICK R. (Reporting)
Form 4/A
09/04/2024
8:13 PM		HOUGEN ELIZABETH L (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:51 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:52 PM		Ionis Pharmaceuticals (Issuer)
Monia Brett P (Reporting)
Form 4/A
09/04/2024
7:42 PM		BENNETT C FRANK (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/04/2024
7:42 PM		Cadoret-Manier Onaiza (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4/A
09/03/2024
6:18 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:27 PM		Geary Richard S (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
2:35 PM		Ionis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
10:15 AM		Ionis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2024
4:02 PM		BERTHELSEN SPENCER R (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
07/17/2024
4:02 PM		Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM		HERMAN JOAN E (Reporting)
Ionis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:02 PM		Ionis Pharmaceuticals (Issuer)
KLEIN JOSEPH III (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM		Ionis Pharmaceuticals (Issuer)
LOSCALZO JOSEPH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM		Ionis Pharmaceuticals (Issuer)
PARSHALL B LYNNE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
4:03 PM		Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:11 PM		Diaz Allene M. (Reporting)
Ionis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
2:13 PM		Ionis Pharmaceuticals (Issuer)
YANG MICHAEL J. (Reporting)
Form 4/A
07/03/2024
1:48 PM		Ionis Pharmaceuticals (Issuer)
WENDER JOSEPH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:IONS) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
How to trade Executive Order 14154
Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...
Porter & Company | Sponsored
Major AI announcement for 2025
BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI Stocks
Brownstone Research | Sponsored